Skip to main content
Clinical Trials/NCT00491062
NCT00491062
Completed
Not Applicable

Analysis of Dopamine Neuronal Cell Loss Within the Enteric Nervous System in Parkinson's Disease

Nantes University Hospital1 site in 1 countryJune 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Nantes University Hospital
Locations
1
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The "core" of the neuronal lesions in Parkinson's disease (PD) is the progressive degeneration of dopamine neurons in the substantia nigra. A significant loss of dopamine neurons and the presence of Lewy bodies (a pathological hallmark in PD) in enteric neurons have also been reported in that disease. These lesions may explain the frequent gastro-intestinal dysfunction observed in PD patients. Alterations of other neuronal populations within the enteric nervous system (ENS) as well as the mechanisms responsible for these lesions (type of cell death, alteration of neuromediators gene expression) remain to be identified. The aim of the study is to demonstrate that alterations of the human ENS in PD can be evidenced by bowel biopsies and to determine whether they are correlated to the severity of motor disability and to gastrointestinal dysfunction.

Registry
clinicaltrials.gov
Start Date
June 2007
End Date
November 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Parkinson's disease patients at 3 different stages:
  • Early PD (before L-DOPA-induced complication);
  • Patients with L-DOPA-induced complication;
  • Patients with balance impairment or cognitive decline.
  • Controls: patient at risk of colic cancer for whom a coloscopy is required.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials